Protocol summary

Study aim
To compare the frequency of antibiotic use within four weeks of enrollment among patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) managed using CRP point-of-care testing-guided antibiotic prescribing versus usual clinical care.
Design
Single-center, two-arm, open-label, parallel-group randomized controlled trial involving 164 patients (82 per group), with 1:1 computer-generated randomization and four-week follow-up. No blinding will be performed.
Settings and conduct
This open-label RCT will be conducted at Sheikh Zayed Hospital, Rahim Yar Khan. A total of 164 patients will be randomized into CRP-guided and usual-care groups, with follow-ups at weeks 1, 2, and 4. No blinding will be performed.
Participants/Inclusion and exclusion criteria
Inclusion criteria: Patients aged 40–60 years. Both male and female patients. Patients with a previous clinical diagnosis of COPD presenting with acute exacerbation according to the study's operational definition. Exclusion criteria: Pregnant women. Antibiotic use within the preceding 5 days. Patients with malignancy. Patients unable or unwilling to provide informed consent or comply with the study protocol. Patients currently participating in or recently enrolled in another research study.
Intervention groups
Patients will be randomized into two groups. The intervention group will receive CRP-guided antibiotic management (CRP ≥20 mg/L), while the control group will receive usual clinical care. Both groups will be followed up at 1, 2, and 4 weeks to assess antibiotic use and clinical outcomes.
Main outcome variables
The primary outcome measure is the proportion of patients receiving antibiotics within four weeks of enrollment, compared between the CRP-guided group and the usual-care group.

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20261102071643N1
Registration date: 2026-11-07, 1405/08/16
Registration timing: retrospective

Last update: 2026-11-07, 1405/08/16
Update count: 0
Registration date
2026-11-07, 1405/08/16
Registrant information
Name
Muhammad waqas Jamil
Name of organization / entity
Pulmonology department, Sheikh zayed Hospital
Country
Pakistan
Phone
+92 331 3304141
Email address
jamilwaqas4@gmail.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2026-02-01, 1404/11/12
Expected recruitment end date
2026-07-31, 1405/05/09
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
C reactive protein point of care testing for safely reducing the use of antibiotics for acute exacerbation of COPD
Public title
C reactive protein point of care testing for safely reducing the use of antibiotics for acute exacerbation of COPD
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Age of 40-60 years Both genders Clinically diagnosed cases of AECOPD as per operational definition
Exclusion criteria:
Pregnant women. Patients who had received antibiotics within the past 5 days. Those involved in other research studies or those who had recently participated in the trial. Patients considered unable or unwilling to follow the protocol or provide consent. Malignancy
Age
From 40 years old to 60 years old
Gender
Both
Phase
N/A
Groups that have been masked
No information
Sample size
Target sample size: 164
Randomization (investigator's opinion)
Randomized
Randomization description
Eligible patients will be randomized individually in a 1:1 ratio into two parallel groups: the CRP point-of-care testing-guided group (Group A) and the usual-care group (Group B). Simple randomization will be performed using a computer-generated random sequence prepared through statistical software. Each participant will be assigned a unique study identification number, and the random allocation sequence will determine the treatment group. Allocation concealment will be ensured using sequentially numbered, opaque, sealed envelopes (SNOSE), prepared according to the computer-generated randomization sequence by an independent person not involved in patient recruitment or treatment allocation. After confirming eligibility and obtaining written informed consent, the investigator will open the next sequentially numbered envelope to determine the participant's group assignment. No stratification will be performed. The study will be open-label; therefore, blinding of patients and treating physicians will not be feasible. However, allocation concealment will be maintained until the participant has been enrolled and assigned to a group.
Blinding (investigator's opinion)
Not blinded
Blinding description
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
ERB, Sheikh Zayed Hospital, Rahim Yar Khan
Street address
Hospital Road
City
Rahim Yar Khan
Postal code
64200
Approval date
2025-04-11, 1404/01/22
Ethics committee reference number
137/IRB/SZMC/SZH

Health conditions studied

1

Description of health condition studied
Acute exacerbation of chronic obstructive pulmonary disease (AECOPD).
ICD-10 code
J44.1
ICD-10 code description
Chronic obstructive pulmonary disease with (acute) exacerbation

Primary outcomes

1

Description
Proportion of patients receiving antibiotics in the CRP-guided group compared with the usual-care group.
Timepoint
Within four weeks of enrolment, assessed at initial consultation and follow-up visits at weeks 1, 2, and 4.
Method of measurement
Measured as the number and percentage of patients receiving at least one antibiotic prescription during the four-week follow-up period, based on clinical records and patient follow-up interviews, and compared between the two groups.

Secondary outcomes

1

Description
Proportion of patients receiving antibiotics at the initial consultation in both study groups.
Timepoint
At the initial consultation (baseline).
Method of measurement
Recorded as the number and percentage of patients prescribed antibiotics at the initial consultation, based on prescription records.

Intervention groups

1

Description
Intervention group: CRP-guided antibiotic prescribing. Patients will undergo CRP point-of-care testing, and antibiotic prescribing will be guided by CRP levels ≥20 mg/L in conjunction with clinical assessment by a consultant pulmonologist.
Category
Treatment - Other

2

Description
Control group: Usual care. Antibiotic prescribing will be based on clinical assessment and the judgment of the treating consultant pulmonologist without CRP point-of-care testing.
Category
Treatment - Other

Recruitment centers

1

Recruitment center
Name of recruitment center
Sheikh Zayed Hospital
Full name of responsible person
Dr Muhammad Waqas Jamil
Street address
Hospital Road
City
Rahim Yar Khan
Postal code
64200
Phone
+92 331 3304141
Email
jamilwaqas4@gmail.com

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Sheikh Zayed Hospital
Full name of responsible person
Dr Muhammad Waqas Jamil
Street address
Hospital Road
City
Rahim Yar Khan
Postal code
64200
Phone
+92 331 3304141
Email
jamilwaqas4@gmail.com
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Sheikh Zayed Hospital
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Sheikh Zayed Hospital
Full name of responsible person
Dr Muhammad Waqas Jamil
Position
Speciality Registrar
Latest degree
Medical doctor
Other areas of specialty/work
pulmonology
Street address
Hospital Road
City
Rahim Yar Khan
Province
Punjab
Postal code
64200
Phone
+92 331 3304141
Email
jamilwaqas4@gmail.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Sheikh Zayed Hospital
Full name of responsible person
Dr Muhammad Waqas Jamil
Position
Speciality Registrar
Latest degree
Medical doctor
Other areas of specialty/work
Pulmonology
Street address
Hospital Road
City
Rahim Yar Khan
Province
Punjab
Postal code
64200
Phone
+92 331 3304141
Email
jamilwaqas4@gmail.com

Person responsible for updating data

Contact
Name of organization / entity
Sheikh Zayed Hospital
Full name of responsible person
Dr Muhammad Waqas Jamil
Position
Speciality Registrar
Latest degree
Medical doctor
Other areas of specialty/work
pulmonology
Street address
Hospital Road
City
Rahim Yar Khan
Province
Punjab
Postal code
64200
Phone
+92 331 3304141
Email
jamilwaqas4@gmail.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
No - There is not a plan to make this available
Justification/reason for indecision/not sharing IPD
Due to patient confidentiality, data privacy concerns, and institutional ethical requirements, deidentified individual participant data will not be made publicly available.
Study Protocol
Yes - There is a plan to make this available
Statistical Analysis Plan
Yes - There is a plan to make this available
Informed Consent Form
No - There is not a plan to make this available
Clinical Study Report
No - There is not a plan to make this available
Analytic Code
No - There is not a plan to make this available
Data Dictionary
No - There is not a plan to make this available
Title and more details about the data/document
Study Protocol: Final approved research protocol entitled "C-Reactive Protein Point-of-Care Testing for Safely Reducing the Use of Antibiotics for Acute Exacerbation of COPD." Statistical Analysis Plan: Document describing the planned statistical methods, outcome measures, and comparative analysis of the CRP-guided and usual-care groups.
When the data will become available and for how long
The documents will be available after publication of the primary study results and will remain available for five years thereafter upon reasonable request.
To whom data/document is available
The documents will be available to researchers, academic institutions, and healthcare professionals interested in conducting related clinical research.
Under which criteria data/document could be used
Qualified researchers, clinicians, and academic investigators with a scientifically sound research proposal and appropriate institutional or ethics approval, if applicable.
From where data/document is obtainable
Requests should be sent by email to the corresponding investigator. The study protocol and informed consent form will be provided electronically (PDF format) after approval of the request by the principal investigator.
What processes are involved for a request to access data/document
Researchers should submit a written request to the principal investigator stating the purpose of the request and intended use of the documents. Requests will be reviewed within 30 days, subject to institutional approval. Approved documents will be shared electronically
Comments
No individual participant data will be shared. Only the study protocol and statistical analysis plan will be made available under the specified conditions.
Loading...